Quetiapine Fumarate XR Tablets
SPE2D223R0010 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2023-05-19. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Amendment 0003 SPE2D2-23-R-0010 issued May 2, 2023 to extend the closing date from May 5, 2023 3:00 PM EDT to May 19, 2023 3:00 PM EDT. Amendment 0002 SPE2D2-23-R-0010 issued April 18, 2023 to extend the closing date from April 21, 2023 3:00 PM EDT to May 5, 2023 3:00 PM EDT. Amendment 0001 SPE2D2-2
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
Questions
What is solicitation SPE2D223R0010?
Quetiapine Fumarate XR Tablets, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING). Responses are due 2023-05-19.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.